|
Match
|
Document |
Document Title |
|
|
7615545 |
Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology
This invention relates to a method of preventing pregnancy and treating PMS including PMDD. More particularly, the invention relates to a method, which involves administering one of several...
|
|
|
7601707 |
Method for instantly relieving tissue inflammation
A method for treating an inflamed tissue includes locally applying a solution comprising a corticosteroid and an anesthetic agent to the inflamed tissue so that the solution directly contacts the...
|
|
|
7589082 |
Pharmaceutical formulation for contraception and hormone-replacement therapy
The present invention provides slow release estradiol-progesterone formulations that can be used in either contraception or hormone replacement therapies. The formulations comprise shaped particles...
|
|
|
7572779 |
Oral pharmaceutical products containing 17β-estradiol-3-lower alkanoate, method of administering the same and process of preparation
A pharmaceutical dosage unit for oral administration to a human female comprising a therapeutically effective amount of 17β-estradiol-3-lower alkanoate, most preferably 17β-estradiol-3-acetate,...
|
|
|
7569560 |
Extended cycle multiphasic oral contraceptive method
A multiphasic method of contraception provides for sequentially administering to a female of child bearing age: (a) a Phase I composition containing a progestogen and an estrogen for about 4 to...
|
|
|
7560448 |
Enhancement of activity and/or duration of action of soft anti-inflammatory steroids for topical or other local application
Methods and compositions for enhancing the activity and/or duration of action of loteprednol etabonate and other soft anti-inflammatory steroids of the haloalkyl...
|
|
|
7538099 |
Antiprogestin method and kit for reducing side effects associated with low dosage HRT, oral contraception and regulating menses
Menses regulation and, when desired, contraception is achieved at low doses of estrogen and progestin, which otherwise would create episodes of breakthrough bleeding and/or withdrawal amenorrhea,...
|
|
|
7524833 |
Method and apparatus for concentrating and stabilizing conjugated estrogens from mare urine
A method and apparatus for concentrating and stabilizing conjugated estrogens from pregnant mare urine on solid adsorbent supports to obtain a starting material for pharmaceuticals that contain a...
|
|
|
7439235 |
Method for obtaining estrogens from mare's urine
A method for obtaining an extract from a natural mixture of conjugated estrogens from the urine of pregnant mares (PMU) by solid-phase extraction on semipolar adsorption resins in which the...
|
|
|
7335650 |
Composition
There is provided a pharmaceutical composition comprising (i) a compound of the formula
wherein: X is a hydrocarbyl ring having at least 4 atoms in the ring; K is a hydrocarbyl group; Rs is a...
|
|
|
7320970 |
Low dose estrogen interrupted hormone replacement therapy
A hormone replacement therapy, comprising a plurality of daily doses of a pharmaceutical preparation, the doses being administered continuously and consecutively in alternating phases of three...
|
|
|
7320969 |
Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology
This invention relates to a method of preventing pregnancy and treating PMS including PMDD. More particularly, the invention relates to a method, which involves administering one of several...
|
|
|
RE39861 |
Methods of extended use oral contraception
A method of female contraception involves administering a combination of estrogen and progestin for 60-110 consecutive days in which the daily amounts of estrogen and progestin are equivalent to...
|
|
|
7265101 |
Appetite-suppressing compositions and methods
The invention relates to appetite-suppressing compositions obtained from botanical sources. More specifically, the invention relates to appetite-suppressing compositions comprising an extract...
|
|
|
7220733 |
Separation of cresol from mares' urine
A method of separating cresol from mares' urine by pervaporation using pore-free polymeric silicone membranes in which starting urine solutions containing high-quality and -quantity conjugated...
|
|
|
7214672 |
Preventives/remedies for inflammatory airway diseases
A preventive and/or therapeutic agent for inflammatory respiratory tract diseases containing, as an active ingredient, a steroid derivative represented by the following formula (1):
(wherein R...
|
|
|
RE39592 |
Extended release growth promoting two component composition
An extended release composition comprising a first composition comprising growth promoters and a second composition comprising growth promoters and a biodegradable polymer is described. A method of...
|
|
|
7196074 |
Methods of making, using and pharmaceutical formulations comprising 7α, 11β-dimethyl-17β-hydroxyestra-4, 14-dien-3-one and 17 esters thereof
Methods of using 7α,11β-dimethyl-17β-hydroxyestra-4,14-dien-3-one (III)
and 17 esters thereof for various hormonal therapies, oral and parenteral dosage forms comprising these actives, and...
|
|
|
7179799 |
(3) and (6) substituted estrogenic compounds
Novel estrogenic compounds of Formula I are provided.
wherein the bond represented by the wavy line may be a single or double bond such that when the wavy line is a single bond, R 1 is...
|
|
|
7179798 |
Methods and compositions for the treatment of pain and other hormone-allergy-related symptoms using dilute hormone solutions
A method and composition for the treatment of hormone allergy is disclosed. The method relates to using progesterone dilutions, or any other steroid hormone, to treat the systemic symptoms of...
|
|
|
7122578 |
Method and composition for treating mammalian diseases and injuries which cause pain, erythema, swelling, crusting, ischemia scarring and excess white blood cell infiltration
A method for treating the disease state in mammals caused by mammalian cells involved in the inflammatory response is disclosed. Mammalian cells participating in the inflammatory response are...
|
|
|
7108867 |
Process for preparing particles
A process for preparing particles of a substance, such as a protein or polypeptide, comprising: (a) preparing a first liquid comprising water, the substance and a modulator, wherein the modulator...
|
|
|
7081451 |
Method and apparatus for concentrating and stabilizing conjugated estrogens from mare urine
A method and apparatus for concentrating and stabilizing conjugated estrogens from pregnant mare urine on solid adsorbent supports to obtain a starting material for pharmaceuticals that contain a...
|
|
|
7078394 |
Low dose estrogen interrupted hormone replacement therapy
A hormone replacement therapy, comprising a plurality of daily doses of a pharmaceutical preparation, the doses being administered continuously and consecutively in alternating phases of three...
|
|
|
7078059 |
Treatment of bone diseases
The invention provides a method for enhancing bone formation, inhibiting osteoclastic differentiation and/or activating osteoblastic differentiation whereby to manage, treat or achieve prophylaxis...
|
|
|
7067505 |
Di-steroidal prodrugs of estradiol
The present invention is a di-steroidal prodrug of estradiol having the following formula:
|
|
|
7067504 |
Di-steroidal prodrugs of ethinyl estradiol
The present invention is a di-steroidal prodrug of ethinyl estradiol according to formula I:
|
|
|
7060693 |
Ajuga turkestanica extract and its cosmetic uses
The invention relates to an extract of the plant Ajuga turkestanica containing at least one ecdysteroid and at least one iridoid and obtainable by extraction of at least part of said plant by...
|
|
|
7056906 |
Combinations of hormone replacement therapy composition(s) and sterol absorption inhibitor(s) and treatments for vascular conditions in post-menopausal women
The present invention provides compositions, therapeutic combinations and methods including: (a) at least one hormone replacement therapy composition; and (b) at least one sterol absorption...
|
|
|
7045513 |
DHEA composition and method
Disclosed are improved pharmaceutical formulations comprising dehydroepiandrosterone (DHEA), enriched in selected polymorphic forms, for therapeutic applications. In one embodiment, the formulation...
|
|
|
7037907 |
Estradiol conjugates and uses thereof
A conjugated prodrug of an estradiol compound conjugated to a biological activity modifying agent.
|
|
|
7030104 |
Topical oestroprogestational compositions with a systemic effect
The present invention relates to the field of therapeutic chemistry and more especially to the realization of new galenic forms intended to be applied on the skin. More particularly it relates to...
|
|
|
7025979 |
Male contraceptive formulation comprising norethisterone
A formulation for male contraception comprising a progestin possessing both estrogenic and androgenic properties is remarkably effective for spermatogenesis suppression in males. The progestin...
|
|
|
7012060 |
TNF receptor and steroid hormone in a combined therapy
The present invention relates to the use of a TNF Receptor together with a steroid hormone to produce a pharmaceutical composition for the treatment of lethal bacterial and viral infections as well...
|
|
|
6995149 |
Contraceptive process and kit for female mammals, comprising a combination of gestagen and oestrogen
The present invention relates to a female mammal contraceptive process consisting of the sequential administration for at least 28 days of (a) a gestagen in an ovulation-preventing dose for at...
|
|
|
6987101 |
Therapeutic gestagens for the treatment of premenstrual dysphoric disorder
A method for treating premenstrual dysphoric disorder comprises administering a therapeutically effective amount of a gestagen. Optionally, a natural or synthetic estrogen is also administered. In...
|
|
|
6984633 |
Method to treat cardiofibrosis with a combination therapy of an angiotensin II antagonist and epoxymexrenone
A therapeutic method is described for treating cardiofibrosis or cardiac hypertrophy using a combination therapy comprising a therapeutically-effective amount of an angiotensin II receptor...
|
|
|
6977250 |
Prevention of ovarian cancer by administration of progestin products
The present invention relates to methods for preventing the development of epithelial ovarian cancer by administering progestin products, either alone or in combination with other agents such as...
|
|
|
6962908 |
Oral pharmaceutical products containing 17 β-estradiol-3-lower alkanoate, method of administering the same and process of preparation
A pharmaceutical dosage unit for oral administration to a human female comprising a therapeutically effective amount of 17β-estradiol-3-lower alkanoate, most preferably 17β-estradiol-3-acetate,...
|
|
|
6911438 |
Hormone replacement formulation
The formulation comprises a combination of three estrogens and selected amount of other elements. The three estrogens include 2-hydroxyestrone, 17-beta estradiol, and estriol. The amount of 17-beta...
|
|
|
6906049 |
Contraceptive medicine based on a progestational agent and an oestrogen and preparation method
The present invention relates to the field of chemistry and more particularly to that of therapeutic chemistry. The invention relates more particularly to novel contraceptive compositions formed...
|
|
|
6905705 |
Multipack for removing filled bags in a predetermined sequence
This invention provides for, inter alia, a multipack comprising at least two different bags, wherein the bags are arranged in a predetermined sequence and are joined together in a single block. The...
|
|
|
6884793 |
Combination preparation for contraception based on natural estrogens
The combination preparation for contraception includes from 2 to 4 first stage daily dosage portions each including an effective amount of at least one natural estrogen as sole active ingredient,...
|
|
|
6881729 |
Bile compound and method of controlling behavior of lampreys therewith
Novel compounds isolated from the bile of male sea lampreys are described, in particular, 7α,12α,24-trihydroxy-5α-cholan-3-one-24-sulfate and 7α,12α-dihydroxy-5α-cholan-3-one-24-oic acid and...
|
|
|
6881728 |
14-β, 17-α-hydroxymethylandrostane derivatives as androgens
Androgenic steroids having a (14β,17α-)-17-(hydroxymetheyl) configuration, useful for the preparation of male contraceptives and pharmaceutical formulations for the treatment of androgen...
|
|
|
6875758 |
Method of treating hyperlipidemic and hyperglycemic conditions in mammals using pregnadienols and pregnadienones
The invention provides a method of using pregnadienones and pregnadienols represented by the structural formula (I) as shown herein below
Wherein X═OH or O or combination thereof and...
|
|
|
6869941 |
Combination of drospirenone and an estrogen sulphamate for HRT
A pharmaceutical dosage unit comprising drospirenone and an estrogen sulphamate, such as an estradiol sulphamate or an estriol sulphamate for use in hormone replacement therapy is disclosed. This,...
|
|
|
6855704 |
Process for isolating conjugated estrogens
The present invention relates to a process for extracting conjugated estrogens from pregnant mare urine. The present invention further relates to a process for obtaining a natural mixture of...
|
|
|
6855703 |
Pharmaceutical compositions of conjugated estrogens and methods of analyzing mixtures containing estrogenic compounds
A composition of matter is provided having a mixture of active estrogenic compounds. The mixture is present in chemically pure form. The mixture includes salts of conjugated estrone, conjugated...
|
|
|
6831073 |
Hormonal composition consisting of an oestrogen compound and of a progestational compound
A method of treating estrogenic deficiencies in women while further avoiding the appearance of osteoporosis, withdrawal bleeding and cardiovascular diseases in post-menopausal women without any...
|